Infection and Immunity, July 2001, p. 4276-4286, Vol. 69, No. 7
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4276-4286.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois 60611
Received 30 November 2000/Returned for modification 15 January 2001/Accepted 28 March 2001
| |
ABSTRACT |
|---|
|
|
|---|
In the course of characterizing a locus involved in heme utilization, we identified a Legionella pneumophila gene predicted to encode a protein with homology to the product of the Salmonella enterica serovar Typhimurium pagP gene. In Salmonella, pagP increases resistance to the bactericidal effects of cationic antimicrobial peptides (CAMPs). Mutants with insertions in the L. pneumophila pagP-like gene were generated and showed decreased resistance to different structural classes of CAMPs compared to the wild type; hence, this gene was designated rcp for resistance to cationic antimicrobial peptides. Furthermore, Legionella CAMP resistance was induced by growth in low-magnesium medium. To determine whether rcp had any role in intracellular survival, mutants were tested in the two most relevant host cells for Legionnaires' disease, i.e., amoebae and macrophages. These mutants exhibited a 1,000-fold-decreased recovery during a Hartmannella vermiformis coculture. Complementation of the infectivity defect could be achieved by introduction of a plasmid containing the intact rcp gene. Mutations in rcp consistently reduced both the numbers of bacteria recovered during intracellular infection and their cytopathic capacity for U937 macrophages. The rcp mutant was also more defective for lung colonization of A/J mice. Growth of rcp mutants in buffered yeast extract broth was identical to that of the wild type, indicating that the observed differences in numbers of bacteria recovered from host cells were not due to a generalized growth defect. However, in low-Mg2+ medium, the rcp mutant was impaired in stationary-phase survival. This is the first demonstration of a pagP-like gene, involved in resistance to CAMPs, being required for intracellular infection and virulence.
| |
INTRODUCTION |
|---|
|
|
|---|
Legionella pneumophila is a facultative intracellular parasite of human monocytes, macrophages, and protozoa (48, 63, 69). In the natural environment, Legionella species occupy the niches of soil and water, either free-living, in biofilms, or, more commonly, residing within amoebal hosts (29, 69). Problems occur when legionellae enter and replicate in human-made water systems, from which inhalation of bacterium-ladened aerosols leads to the establishment of a pneumonia referred to as Legionnaires' disease (28).
Pathogens, such as L. pneumophila, that adopt an intracellular lifestyle must possess multiple strategies to overcome or evade the defense system of the host cell. For example, mammalian macrophages and amoebae are well equipped to bring about the demise of engulfed bacteria via the action of both oxygen-independent and -dependent mechanisms (31, 40, 53). Oxygen-independent mechanisms include cationic antimicrobial peptides (CAMPs), a group of structurally diverse polypeptides that are thought to kill by membrane damage due to pore formation (41, 53). L. pneumophila overcomes much of the killing mechanisms of the host cell by initially residing in a phagosome with limited ability to fuse with lysosomes, the source of the majority of antibacterial substances within the phagocyte (13, 47, 57, 78, 79). However, several lines of evidence suggest that L. pneumophila is exposed to lysosomal factors and likely possesses resistance factors against at least some of them. For example, some L. pneumophila mutants, which are readily delivered to a macrophage phagolysosome, do survive, albeit with little or no replication (9, 46, 56). Also, recent evidence suggests that phagolysosomal fusion does occur late in the intracellular infection cycle (75). Furthermore, extracellular L. pneumophila is inherently resistant to polymyxin B (PmB), a CAMP that is actually used for selection of Legionella spp. from clinical and environmental samples (23).
Although catalase/peroxidase and superoxide dismutase enzymes are known to promote L. pneumophila resistance to oxygen-dependent killing (2, 4, 74), the Legionella factors involved in CAMP resistance are completely unknown. Indeed, knowledge of bacterial CAMP resistance determinants is only beginning to emerge (7, 26, 67). The majority of the literature on CAMP resistance is from Salmonella enterica serovar Typhimurium, where several determinants have been identified, such as pagP (37-39, 81). This gene is transcriptionally activated by PhoPQ (hence the pagP gene designation as PhoP-activated gene P), a two-component regulator of genes involved in both enterocyte invasion and survival within macrophages (5, 39, 62). However, the importance of PagP in intracellular infections is not known (6).
Previous efforts by our group to isolate determinants important for iron acquisition and utilization in L. pneumophila led to the identification of a gene responsible for hemin binding, hbp (65). Here, we demonstrate that in the hbp region of the L. pneumophila chromosome there is an open reading frame whose product has homology with PagP. The aims of our further investigations were to identify whether the pagP-like gene in L. pneumophila has a role in CAMP resistance and, more importantly, whether it has any relevance for intracellular infection and virulence.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and growth conditions.
The strains of
L. pneumophila and other Legionella spp. used
during these studies are listed in Table
1. L. pneumophila strain 130b
(Wadsworth) was used for mutagenesis of the Legionella
pagP-like gene and subsequently served as the wild-type control. A
pBR322 plasmid library of 3- to 6-kb Sau3AI-restricted 130b
genomic DNA was maintained in Escherichia coli K-12 strain
HB101 (44). In the CAMP susceptibility assay,
Pseudomonas aeruginosa strain PAK was used as a sensitive
control (26). L. pneumophila strains were
routinely grown on standard buffered charcoal-yeast extract (BCYE) agar
for 3 days at 37°C (22). For selection of allelic exchange mutations, BCYE agar was supplemented with 5% (wt/vol) sucrose (54). For growth curves, L. pneumophila
was grown either in buffered yeast extract broth or in chemically
defined liquid medium (CDM) at 37°C with shaking at 250 rpm (Lab-Line
Instruments model 3525) (54). The components of CDM have
been described elsewhere (68); briefly, the base consisted
of 3-(N-morpholino)propanesulfonic acid buffer, NaCl and
KH2PO4, which was supplemented with reduced glutathione and a variety of amino acids and trace metals, including 0.7 mM MgSO4. For CDM cultures, the starting inocula were
from buffered yeast extract (BYE) cultures in the logarithmic phase of
growth, i.e., with an optical density at 660 nm (OD660) of 0.9 to 1.2. Bacteria were washed three times in CDM base before resuspension to an OD660 of 0.15 in CDM containing various
amounts of Mg2+. Luria-Bertani broth or agar was used for
growth of E. coli and P. aeruginosa
(70). Where appropriate, the medium was supplemented with
the following antibiotics at final concentrations suitable for L. pneumophila (or E. coli): kanamycin (KAN), 25 µg/ml
(50 µg/ml); and chloramphenicol (CHL), 3 or 6 µg/ml (30 µg/ml).
|
DNA sequence analysis. Double-stranded sequence was obtained from pEH12, a member of the pBR322 library containing hbp and surrounding genes, by the dideoxy chain termination method with 35S-dATP and Sequenase (Amersham Life Sciences, Arlington Heights, Ill.) (65). Sequencing reactions were performed according to the manufacturer's recommendations using pUC-based subclones of pEH12, with vector-based primers. Nucleotide sequences were analyzed with PCGENE (IntelliGenetics), and homology searches were conducted through GenBank at the National Center for Biotechnology Information.
Mutation and complementation of an L. pneumophila
pagP-like gene.
A mutation in the cloned
pagP-like gene of strain 130b was generated by insertion of
a 1.1-kb KAN resistance cassette at the AflII site of pEH12
(Fig. 1A), resulting in plasmid pBOC16. A 2.9-kb BamHI-SacI fragment from pBOC16 was cloned
into pBOC20, resulting in pTA2 (Fig. 1A). Plasmid pBOC20 is based on a
ColE1 replicon and facilitates allelic exchange in L. pneumophila by virtue of its sacB gene
(54). Production of competent 130b cells and
electroporation of pTA2 into L. pneumophila were achieved as
previously described (54). Potential mutants were selected based on CHL sensitivity and KAN and sucrose resistance, which are
indicative of the introduction of the mutated gene into the 130b
chromosome by homologous recombination. Verification of mutant genotypes was carried out by PCR and Southern hybridization (3, 54, 65, 70). A DNA fragment specific to the pagP-like
gene encoded within 0.9 kb was generated by PCR using primers PAGP-F (5'-TGA TTC ATT GTC TGG CGA CC-3') and PAGP-R (5'-GCC
AAG ATT ACA GCA CCG AT-3'). Primers were generated by the
Northwestern University Biotechnology Center using an Applied
Biosystems DNA synthesizer. Genomic DNA was isolated from L. pneumophila as described previously (24). For
complementation analysis, the PCR product amplified using PAGP-F and
PAGP-R was cloned into pGEMTEasy (Promega, Madison, Wis.) and then
subcloned on a 0.9-kb NotI fragment into the low-copy-number
CHL resistant pSU2719 (18), resulting in pS14. Another
complementing plasmid, pS25, was constructed by cloning the 1.8-kb
BamHI-SacI fragment containing the
pagP-like gene from pEH12 into pSU2719.
|
CAMP microdilution susceptibility assay.
C18G, a synthetic
-helical peptide based on the carboxy terminus of human platelet
factor IV (21), and PmB (7,770 U/mg; U.S. Biochemicals;
Swampscott, Mass.) were used to check the resistance of 130b and its
mutants to CAMPs. To assess this resistance, a standard microdilution
susceptibility assay, which uses minimal amounts of each CAMP, was
performed (21, 36, 53, 73, 81). Bacteria grown in BYE,
CDM, or CDM containing various amounts of Mg2+ were diluted
to 5 × 104 CFU/ml in 2× BYE. In triplicate wells of
a 96-well microtiter tray, 50 µl of bacterial suspension was added to
an equal volume of various concentrations of C18G or PmB (diluted in
sterile distilled water from a fresh stock solution). Thus, the
incubation medium throughout the CAMP resistance assays was BYE to
prevent any observed differences in MIC being attributable to
differences in growth potential. Following incubation at 37°C for
16 h (for P. aeruginosa PAK) or for 30 h (for
L. pneumophila strains), the lowest concentration of C18G or
PmB resulting in no visible growth was deemed to be the MIC
(36). From wells where no growth was evident, four 10-µl samples were spotted onto BCYE agar (for L. pneumophila) or
Luria-Bertani agar (for PAK) to assess the minimum bactericidal
concentration (MBC) (36). To facilitate maximum
availability of the peptides, all stages of the assay were performed
using polypropylene plasticware, as the negatively charged surface of
polystyrene plasticware has been shown to bind CAMPs (36).
Intracellular infection of macrophages and amoebae by L. pneumophila. Intracellular infection by L. pneumophila strains was assessed in human U937 cells (1, 54, 65, 66, 76) differentiated into macrophage-like cells by treatment with phorbol myristate acetate and in Hartmannella vermiformis amoebae (17, 19, 29, 54, 71). Assessment of the intracellular growth kinetics of L. pneumophila in U937 macrophages was performed as previously reported (54). Briefly, U937 cells were routinely cultivated in RPMI 1640 medium with L-glutamine (Gibco Life Technologies, Rockville, Md.) supplemented with 10% heat-inactivated fetal calf serum (HyClone, Logan, Utah) and 2.5 ml of amphotericin B (Fungizone; Gibco Life Technologies) in a 5% CO2 incubator at 37°C. Using a multiplicity of infection (MOI) of 1, 106 adherent U937 macrophages were infected with bacteria grown for 3 days on BCYE agar, as standardly performed (1, 3, 21, 56). After a 2-h incubation period to allow bacterial internalization, extracellular bacteria were removed by repeated washing, and then infected monolayers were incubated at 37°C in a 5% CO2 incubator. At various times postinoculation, intracellular bacteria from triplicate wells per strain were released by lysis of the monolayer with 10 µl of 10% saponin (Sigma Chemical Co., St Louis, Mo.). For estimation of viable counts, serial 10-fold dilutions from triplicate wells for each strain were plated on BYCE agar. Initially, cocultures with H. vermiformis and L. pneumophila were performed as described previously (19). Briefly, in 24-well tissue culture trays, 105 H. vermiformis trophozoites were infected with 103 bacteria grown for 3 days on BCYE agar. At 24-h intervals, supernatant samples were taken from triplicate wells and viable counts of extracellular bacteria were estimated. Total numbers of bacteria were also determined in infected H. vermiformis monolayers by lysing amoebae with 10 µl of 10% saponin followed by vigorous pipetting at various time points and assessing viability on BCYE agar. L. pneumophila strains are unable to grow in the medium in which infections of macrophages or H. vermiformis were conducted; thus, increases in bacterial numbers reflect growth within the host cells (19, 66).
Macrophage cytopathicity assay. To determine whether the numbers of bacteria recovered from U937 cells were truly reflective of a diminished infection process, the viability of the macrophages was assessed by the ability of monolayers to reduce the dye alamarBlue (Biosource International, Camarillo, Calif.). Cytopathicity assays were performed as described previously (1, 3, 32, 50). Briefly, 105 U937 macrophages were infected, as described above, at various MOIs. After 2 h, the infected monolayers were washed twice with RPMI to remove extracellular bacteria and then incubated at 37°C. At various time points, alamarBlue was added (1/11 volume in RPMI 1640 medium) to infected monolayers that had been previously washed twice, the monolayers were incubated at 37°C for 3 h, and fluorescence (at an excitation wavelength of 540 nm and an emission wavelength of 584) was assessed.
Pulmonary infection of A/J mice by L. pneumophila. The A/J mouse model mimics the acute L. pneumophila-induced pneumonia in humans (1, 15, 16, 20). The role of rcp in vivo was assessed using standard competition assays (30, 52, 61, 82). Six- to 8-week-old female mice (Jackson Laboratories, Bar Harbor, Maine) were anesthetized and then inoculated by intratracheal injection with a 25-µl bacterial suspension in phosphate-buffered saline. Inocula consisted of 106 CFU of a ca. 1:1 ratio of 130b and NU260, which had been previously grown for 3 days on BCYE agar. At various time points, infected mice were sacrificed. Lungs were collected and disrupted by extrusion of the tissue through a fine-mesh grid into 10 ml of phosphate-buffered saline. Cells were lysed by incubation with 100 µl of 10% saponin for 15 min at 37°C followed by vigorous pipetting. The numbers of viable bacteria and the ratio of 130b to NU260 were estimated by plating 10-fold serial dilutions on both plain and KAN-supplemented BCYE agar.
Detection of pagP-like sequences in other Legionella spp. and SG. Southern hybridization was carried out using BamHI-restricted genomic DNAs from strains representing several L. pneumophila serogroups (SG) and a variety of Legionella spp. The digoxigenin nonradioactive labeling and detection system (Roche Molecular Biochemicals, Indianapolis, Ind.) was used. The probe was produced by PCR incorporation according to the manufacturer's recommendations using primers PAGP-F and PAGP-R and 130b genomic DNA as a template. High-stringency washes (0 to 10% base pair mismatch) were employed for hybridization of the probe to L. pneumophila DNAs (two washes with 2×SSC [1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate]-0.1% sodium dodecyl sulfate [SDS] at room temperature for 15 min and two washes with 0.1× SSC-0.1% SDS at 68°C for 15 min). Low-stringency washes (~30% base pair mismatch) were employed for hybridization of the probe to genomic DNAs from other Legionella spp. (two washes with 5× SSC-0.1% SDS at 50°C for 15 min).
Nucleotide sequence accession number. The GenBank accession number for the L. pneumophila pagP-like gene is AF348322.
| |
RESULTS |
|---|
|
|
|---|
Identification and mutation of an L. pneumophila pagP-like gene. Sequence analysis of the region surrounding hbp encoded on the 130b library clone pEH12 led to the discovery of a gene whose product has 42% identity and 57% similarity to PagP in Salmonella serovar Typhimurium (Fig. 1). The products of the Salmonella pagP gene and the homologous gene in L. pneumophila are both predicted to consist of 186 amino acid residues, providing substantiating evidence that these genes are related (Fig. 1B). The L. pneumophila pagP-like gene product also shows homology, i.e., 43% identity and 57% similarity, to the crcA (camphor resistance A) gene in E. coli K-12 (Fig. 1B). Initially, crcA was characterized as conferring camphor resistance when encoded on a high-copy-number plasmid in combination with cspE and crcB (49). However, recent evidence suggests that the product of crcA is functionally homologous to the Salmonella PagP, prompting an alternative designation from CrcA to the E. coli PagP (11). PagP and CrcA are the only proteins that show strong homology to the product of the pagP-like gene in L. pneumophila (data not shown). Upstream from the 559-bp pagP-like gene on pEH12 is an incomplete open reading frame, orfA, which is transcribed divergently from the pagP-like gene (Fig. 1B). Homology searches suggest that orfA encodes an amino acid permease (data not shown). The pagP-like gene and the downstream hbp are transcribed in the same orientation. Since Northern blot analysis indicates that transcription of hbp is monocistronic (65), the pagP-like gene and hbp are not thought to constitute an operon.
To be able to determine whether the L. pneumophila pagP-like gene has a role similar to that of its Salmonella counterpart, a mutation was introduced into the gene in virulent strain 130b. Mutants were isolated by allelic exchange, whereby the chromosomal copy of the pagP-like gene was replaced by a mutant form containing a KAN insertion cassette at its AflII restriction site, 100 bp from its putative translational start site (Fig. 1A). Two independent mutants whose CHL sensitive and KAN- and sucrose-resistant phenotypes were indicative of homologous recombination of the mutant gene into the chromosome were isolated from separate electroporation events. The mutants, designated NU260 and NU261, were verified by PCR and Southern hybridization to contain the 1.1-kb insertion in the pagP-like gene, using a probe specific to the pagP-like gene (data not shown). All further experiments described here were performed with both NU260 and NU261 with similar results, although, for clarity, only data from NU260 are presented in this paper. Thus, the phenotypes observed result directly or proximately from the mutation in the pagP-like gene and not from spontaneous second-site mutations. However, this does not rule out the possibility of the additional involvement of unlinked genes.Extracellular growth of the L. pneumophila pagP-like
mutant.
The behavior of NU260 in liquid media was assessed to
determine if loss of the pagP-like gene resulted in gross
changes in extracellular growth. No differences were observed in the
growth kinetics of the mutant compared to 130b in standard BYE and CDM broths (Fig. 2A and B). In
Salmonella, the PhoPQ regulon senses Mg2+
cations, and bacterial growth in low-Mg2+ minimal medium
increases the CAMP resistance generated by pagP (39,
72). Thus, we hypothesized that the L. pneumophila
mutants might have reduced survival in low-Mg2+ broth. The
growth maxima of wild type 130b were considerably reduced in standard
CDM compared to BYE and decreased as the concentration of
Mg2+ in CDM was lowered from 0.7 to 0.005 mM (Fig. 2),
which would be predicted from the known metal requirements of L. pneumophila (68). No growth was observed in CDM
lacking added Mg2+ (data not shown). More importantly, as
the Mg2+ concentration of CDM was decreased, NU260 entered
into stationary phase earlier than 130b, with an overall reduction in
the growth maxima of the mutant, although the growth rate was
unaffected (Fig. 2C and D and data not shown). Furthermore, bacterial
viability, as judged by CFU/per milliliter normalized to
OD660, was decreased 20-fold in stationary-phase NU260
grown in 0.005 mM Mg2+-CDM medium compared to 130b (data
not shown). Thus, the L. pneumophila pagP-like gene appears
to be involved in growth and/or survival in low-Mg2+
medium.
|
Resistance of L. pneumophila strains to CAMPs.
Since PagP of Salmonella serovar Typhimurium and E. coli are involved in resistance to CAMPs, we sought to assess the
relative resistance of NU260 to two CAMPs, the cyclical PmB and the
-helical C18G (Table 2). Initially,
experiments determined that CAMP resistance was similar in both
logarithmic and stationary phase (data not shown). Subsequent
investigations were performed with logarithmic-phase bacteria to ensure
maximum viability of the culture. After growth of 130b in BYE, the MIC
and MBC of PmB were 12.5 and 25 to 50 µg/ml, respectively (Table 2).
The MIC of PmB for P. aeruginosa PAK was
3.1 µg/ml, a
fourfold difference compared to that for 130b, in accordance with
Legionella spp. being especially PmB resistant. The MIC and
MBC of PmB for NU260 were 6.2 and 25 µg/ml, respectively (Table 2),
suggesting a role for the pagP-like gene in L. pneumophila resistance to CAMPs. The MIC for C18G of PAK was 32 to
64 µg/ml following growth in BYE. However, L. pneumophila strain 130b appeared to be much more sensitive to the effects of this
CAMP, with the C18G MIC and MBC being 16 and 32 µg/ml, respectively.
The MIC and MBC of C18G for NU260 were 8 and 16 to 32 µg/ml,
respectively. The modest difference in both PmB and C18G resistance
between 130b and NU260 was highly reproducible in independent
experiments (Table 2). Taken together with the significant degree of
sequence homology with PagP proteins in both Salmonella and
E. coli, these data indicate that the L. pneumophila counterpart of PagP plays a role in CAMP resistance.
Hence, we designated the L. pneumophila pagP-like gene
rcp, for resistance to cationic antimicrobial peptides. We
avoided the pag (PhoP-activated gene) designation because
PhoP has not yet been identified in L. pneumophila and the
genetic regulation of rcp is wholly uncharacterized.
|
Intracellular infections by L. pneumophila
strains.
To assess the role of rcp in an intracellular
environment, a phenotype not previously investigated for any
pagP-like gene, U937 macrophages were infected with either
130b or NU260 and then numbers of bacteria were monitored over time. At
0 h, equivalent numbers of bacteria 130b and NU260 were recovered
(Fig. 3). Thus, there was no obvious
defect in the initial stages of infection, i.e., attachment and
invasion. However, the mutant exhibited reduced recovery compared to
the wild-type parent, by 1 log unit at 18 h postinoculation (p.i.)
(Fig. 3). The difference in numbers of recovered bacteria diminished at
later time points, until by 72 h similar numbers of mutant and
wild-type bacteria were recovered (Fig. 3 and data not shown). No
difference was noted in the abilities of NU260 and 130b to survive in
the medium used to culture the macrophages (data not shown). Taken
together, these data suggest that rcp promotes the ability
of L. pneumophila to replicate and/or survive in
macrophages. Since the PmB resistances of wild-type and mutant bacteria
grown for 3 days on BCYE are comparable (data not shown), we suspect
that the difference in numbers of recovered bacteria is due to
intracellular induction of rcp-dependent CAMP resistance.
|
|
|
In vivo virulence studies in A/J mice.
Due to the
intracellular infectivity defect observed in the rcp mutant,
in vivo virulence studies in A/J mice were undertaken (1, 15, 16,
20). Competition assays in which a mixture of 130b and NU260 in
a ca. 1:1 ratio was inoculated by intratracheal injection into A/J mice
were performed to assess the role of rcp in vivo. In
competition assays, increases in the ratio of wild type to mutant over
time reflect the ability of the wild type to outcompete the mutant.
Following 24 h of incubation, the ratio of the wild type to the
mutant recovered from infected lungs increased to 4 (Fig.
6). By 72 h, the ratio of wild type
to mutant had further increased to 100 (Fig. 6). NU260 recovered from
infected animals retained KAN resistance. Thus, we suspect that
rcp promotes L. pneumophila virulence.
|
Detection of pagP-homologous sequences in L. pneumophila SG and other Legionella spp. Probes designed against the rcp gene of 130b were used to check for the presence of pagP-like sequences in other L. pneumophila SG and Legionella spp. Sequences homologous to the probe were observed in all SG tested, i.e., SG 2 to 8, 13, and 14 (Table 1). Under low-stringency conditions (30% base pair mismatch), sequences homologous to the probe were observed in L. birminghamenesis, L. erythra, L. feeleii, L. longbeachae, L. micdadei, and L. parisienesis.
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we have identified a new L. pneumophila infectivity determinant, Rcp, a protein with homology to PagP of Salmonella serovar Typhimurium and E. coli. Sequences homologous to the rcp gene were detected in nine SG of L. pneumophila and in six Legionella spp., suggesting distribution of rcp throughout the genus. The loss of Rcp resulted in modestly decreased Legionella resistance to C18G, a CAMP based on human platelet-derived factor IV, and PmB, a bacterially derived CAMP. This result is entirely in keeping with the established link between PagP and CAMP resistance (39). Growth in low-Mg2+ medium, a condition known to induce Salmonella CAMP resistance, promoted L. pneumophila resistance to C18G and PmB (39). Although induction of CAMP resistance by low Mg2+ concentrations was evident in both the wild type and the rcp mutant, increased induction was demonstrated for 130b, especially against PmB. These results provide substantiating evidence that Rcp is, in part, responsible for resistance to CAMPs in L. pneumophila. Although rcp in L. pneumophila and pagP in Salmonella are genetically and functionally similar, differences between them are apparent. For example, in Legionella the rcp gene is involved in resistance to both C18G and PmB, whereas pagP mediates C18G resistance but not PmB resistance (39). The highly complex composition of CAMPs encountered by the organism in vivo is undefined, and therefore, it is possible that a larger difference could be obtained using a CAMP mixture more similar to that encountered in the intracellular niche occupied by legionellae. In Salmonella and E. coli, PagP functions as a palmitoyl transferase, able to modify the lipid A component of lipopolysaccharide by addition of the fatty acid palmitate (11, 39). The increased acylation is believed to promote resistance to CAMPs by decreasing membrane fluidity and preventing insertion of the peptide (39). Lipid A modifications which increase bacterial CAMP resistance are an emerging theme in gram-negative bacteria (26, 39). For example, in P. aeruginosa, the addition of palmitate to lipid A also increases CAMP resistance in a PhoP-dependent fashion in response to low Mg2+ concentrations (26). Based upon the strong sequence and functional homology with PagP of S. enterica, we strongly suspect that L. pneumophila rcp promotes similar lipid A modifications. Preliminary data suggest that NU260 contains lipopolysaccharide molecules with lower molecular masses (approximately 250 to 300 kDa) than 130b, in accordance with the expected loss of one fatty acid, as judged by electrophoretic separation (U. Zähringer, M. Robey, and N. P. Cianciotto, unpublished results). Detailed analysis to formally prove this hypothesis is currently being pursued. Since the rcp mutant was only partly defective in CAMP resistance, we suspect that additional factors are involved in Legionella resistance to antimicrobial peptides. In Salmonella, CAMP resistance is clearly promoted by several determinants, including the PhoPQ-regulated pagP gene. For example, PmrAB is a two-component regulator of PmB resistance which promotes aminoarabinose additions to lipid A, PgtE is an outer membrane CAMP protease, and waaP is involved in lipopolysaccharide core modifications (37, 38, 81). Thus, in L. pneumophila, as in Salmonella, CAMP resistance appears to be multifactorial.
The growth of both the wild type and NU260 was similar in BYE or CDM, suggesting that mutation of rcp did not cause a generalized growth defect. However, inoculation into low-Mg2+ CDM resulted in lower total growth and decreased bacterial viability of the rcp mutant compared to wild-type 130b. These phenotypes were very similar to the kinetics and viability of Salmonella serovar Typhimurium phoP, mgtA, and mgtCB mutants in low-Mg2+ media (72). The Salmonella mutants are purported to have reduced growth in low-Mg2+ media due to the loss of the Mg2+ transporters (MgtA and MgtCB) or their activator (PhoP) (72). At present, there is no knowledge of Legionella magnesium transport. Thus, clarification of why an rcp mutant has extracellular growth similar to that of Salmonella phoP, mgtA, and mgtCB mutants requires detailed further characterization of rcp.
Here, we demonstrate, for the first time, that a pagP-like gene is important for intracellular growth and/or survival. Indeed, rcp promotes L. pneumophila growth in both H. vermiformis and U937 macrophages, representatives of the two most relevant host cells for Legionella infections. Preliminary data indicate that the rcp mutants are also defective for intracellular infection of peripheral blood monocytes (M. Robey and N. P. Cianciotto, unpublished results). Although other scenarios are possible, it is reasonable to postulate that the decreased infectivity of the rcp mutant is due, at least in part, to decreased CAMP resistance. In U937 macrophages, the difference between the numbers of intracellular bacteria for 130b and the rcp mutant diminished over time. This suggests adaptation of the rcp mutants to their environment, possibly involving the induction of other CAMP resistance mechanisms. Interestingly, a typical cytopathic effect was not elicited by the mutant; i.e., the extent of cytopathicity did not closely correlate with numbers of recovered CFU (3, 32, 42, 50). Recently, mutants have been characterized which are defective for cytopathicity but have no intracellular growth defect and thus remain trapped inside the macrophage (1). However, to our knowledge, NU260 is the first example of an L. pneumophila mutant with an infectivity defect that ultimately achieves a wild-type level of replication in macrophages but lacks a full cytopathic effect. The intracellular infectivity defect of the rcp mutant was more pronounced in H. vermiformis than in U937 macrophages, suggesting greater importance for rcp in amoebal infections. It is possible that (i) amoebae contain more CAMPs than macrophages, (ii) amoebal CAMPs are more accessible to the Legionella intracellular environment, or (iii) amoebal CAMPs are more active against Rcp-induced resistance mechanisms. The notion that the protozoan environment is less permissive has been suggested by the behavior of other Legionella mutants that are more defective in amoebae than in macrophages (17, 27, 71).
Importantly, we have also shown that rcp is important for colonization of the mammalian lung, which is the first demonstration of a pagP-like gene being involved in virulence. The in vivo defect noted in NU260 could be due to changes in the ability of the bacterium to resist CAMPs intracellularly and/or extracellularly. In Salmonella, loss of pagP had no effect on virulence as judged by 50% lethal dose evaluation during intraperitoneal inoculation of BALB/c mice (6). It is possible that the differences in the virulence of pagP in Salmonella and rcp in L. pneumophila reflect inherent differences in assay conditions (i.e., competition assay versus 50% lethal dose or use of BALB/c versus A/J mice). Alternatively, pagP-like genes maybe more important for virulence in legionellosis.
The ability to sense and adapt to changing environmental conditions is highly advantageous to L. pneumophila, an organism that occupies diverse niches, from free-living in water to intracellular in protozoa or macrophages. As the PhoPQ regulon regulates pagP in Salmonella, the question arises whether L. pneumophila rcp is similarly regulated. The unfinished L. pneumophila genome database (www.genome3.cpmc.columbia.edu) contains an open reading frame the product of which has 37% identity and 60% similarity to PhoP in Salmonella serovar Typhimurium. However, the product of this open reading frame also appears to be homologous (44% identity and 61% similarity) to the Salmonella regulatory gene product PmrA, which is involved in PmB resistance. That rcp may be controlled by a PhoPQ-like regulator is suggested by the fact that upstream of the rcp putative transcription start site lie sequences homologous to a motif involved in PhoPQ-dependent Mg2+-responsive induction of transcription in E. coli (51). In Salmonella, Mg2+ is the signal for PhoPQ to transcriptionally activate genes involved in intramacrophage survival, leading to speculation that this cation is limiting within the phagosome (33, 34, 43). That an L. pneumophila rcp mutant shows decreased growth in low-Mg2+ media and decreased infectivity for both amoebae and macrophages suggests that Mg2+ limitation may be an environmental cue for Legionella. Thus, Legionella, like the successful intracellular pathogen Salmonella, may respond to its environment by activating various virulence determinants that facilitate survival and proliferation within the host. Rcp appears to be one such determinant, important for intracellular infection by mediating resistance to CAMPs.
| |
ACKNOWLEDGMENTS |
|---|
This work was funded in part by grant A134937 from the National Institutes of Health awarded to N.P.C.
We thank Tracey Aber Scheel for construction of pTA2 and Joseph Gawronski-Salerno, Ombeline Rossier, Virginia Aragon, and Antje Flieger for assistance during animal studies. We also thank R. Darveau for the kind gift of defensin C18G and A. Hauser for providing the P. aeruginosa strain used during these studies. For helpful discussions and comments, we thank past and present members of the Cianciotto laboratory.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology-Immunology, Northwestern University Medical School, 320 East Superior St., Chicago, IL 60611-3010. Phone: (312) 503-1034. Fax: (312) 503-1339. E-mail: n-cianciotto{at}northwestern.edu.
Editor: B. B. Finlay
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Alli, O. A.,
L. Y. Gao,
L. L. Pedersen,
S. Zink,
M. Radulic,
M. Doric, and Y. Abu Kwaik.
2000.
Temporal pore formation-mediated egress from macrophages and alveolar epithelial cells by Legionella pneumophila.
Infect. Immun.
68:6431-6440 |
| 2. | Amemura-Maekawa, J., S. Mishima-Abe, F. Kura, T. Takahashi, and H. Watanabe. 1999. Identification of a novel periplasmic catalase-peroxidase KatA of Legionella pneumophila. FEMS Microbiol. Lett. 176:339-344[CrossRef][Medline]. |
| 3. |
Aragon, V.,
S. Kurtz,
A. Flieger,
B. Neumeister, and N. P. Cianciotto.
2000.
Secreted enzymatic activities of wild-type and pilD-deficient Legionella pneumophila.
Infect. Immun.
68:1855-1863 |
| 4. |
Bandyopadhyay, P., and H. M. Steinman.
1998.
Legionella pneumophila catalase-peroxidases: cloning of the katB gene and studies of KatB function.
J. Bacteriol.
180:5369-5374 |
| 5. |
Behlau, L., and S. I. Miller.
1993.
A PhoP-repressed gene promotes Salmonella typhimurium invasion of epithelial cells.
J. Bacteriol.
175:4475-4484 |
| 6. |
Belden, W. J., and S. I. Miller.
1994.
Further characterization of the PhoP regulon: identification of new PhoP-activated virulence loci.
Infect. Immun.
62:5095-5101 |
| 7. | Bengoechea, J. A., and M. Skurnik. 2000. Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia. Mol. Microbiol. 37:67-80[CrossRef][Medline]. |
| 8. |
Benson, R. F.,
W. L. Thacker,
H. W. Wilkinson,
R. J. Fallon, and D. J. Brenner.
1988.
Legionella pneumophila serogroup 14 isolated from patients with fatal pneumonia.
J. Clin. Microbiol.
26:382 |
| 9. | Berger, K. H., and R. R. Isberg. 1993. Two distinct defects in intracellular growth complemented by a single genetic locus in Legionella pneumophila. Mol. Microbiol. 7:7-19[Medline]. |
| 10. |
Bibb, W. F.,
P. M. Arnow,
D. L. Dellinger, and S. R. Perryman.
1983.
Isolation and characterization of a seventh serogroup of Legionella pneumophila.
J. Clin. Microbiol.
17:346-348 |
| 11. | Bishop, R. E., H. S. Gibbons, T. Guina, M. S. Trent, S. I. Miller, and C. R. Raetz. 2000. Transfer of palmitate from phospholipids to lipid A in outer membranes of Gram-negative bacteria. EMBO J. 19:5071-5080[CrossRef][Medline]. |
| 12. |
Bissett, M. L.,
J. O. Lee, and D. S. Lindquist.
1983.
New serogroup of Legionella pneumophila, serogroup 8.
J. Clin. Microbiol.
17:887-891 |
| 13. | Bozue, J. A., and W. Johnson. 1996. Interaction of Legionella pneumophila with Acanthamoeba castellanii: uptake by coiling phagocytosis and inhibition of phagosome-lysosome fusion. Infect. Immun. 64:668-673[Abstract]. |
| 14. | Brenner, D. J., A. G. Steigerwalt, G. W. Gorman, H. W. Wilkinson, W. F. Bibb, M. Hackel, R. L. Tyndall, J. Campbell, J. C. Feeley, W. L. Thacker, P. Skaliy, W. T. Martin, B. J. Brake, B. S. Fields, H. V. McEachern, and L. K. Corcoran. 1985. Ten new species of Legionella. Int. J. Syst. Bacteriol. 35:50-59. |
| 15. | Brieland, J., P. Freeman, R. Kunkel, C. Chrisp, M. Hurley, J. Fantone, and C. Engleberg. 1994. Replicative Legionella pneumophila lung infection in intratracheally inoculated A/J mice. A murine model of human Legionnaires' disease. Am. J. Pathol. 145:1537-1546[Abstract]. |
| 16. | Brieland, J., M. McClain, L. Heath, C. Chrisp, G. Huffnagle, M. LeGendre, M. Hurley, J. Fantone, and C. Engleberg. 1996. Coinoculation with Hartmannella vermiformis enhances replicative Legionella pneumophila lung infection in a murine model of Legionnaires' disease. Infect. Immun. 64:2449-2456[Abstract]. |
| 17. | Brieland, J., M. McClain, M. LeGendre, and C. Engleberg. 1997. Intrapulmonary Hartmannella vermiformis: a potential niche for Legionella pneumophila replication in a murine model of legionellosis. Infect. Immun. 65:4892-4896[Abstract]. |
| 18. | Chandler, M. S. 1991. New shuttle vectors for Haemophilus influenzae and Escherichia coli: P15A-derived plasmids replicate in H. influenzae Rd. Plasmid 25:221-224[CrossRef][Medline]. |
| 19. |
Cianciotto, N. P., and B. S. Fields.
1992.
Legionella pneumophila mip gene potentiates intracellular infection of protozoa and human macrophages.
Proc. Natl. Acad. Sci. USA
89:5188-5191 |
| 20. |
Cirillo, J. D.,
S. L. Cirillo,
L. Yan,
L. E. Bermudez,
S. Falkow, and L. S. Tompkins.
1999.
Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila.
Infect. Immun.
67:4427-4434 |
| 21. | Darveau, R. P., J. Blake, C. L. Seachord, W. L. Cosand, M. D. Cunningham, L. Cassiano-Clough, and G. Maloney. 1992. Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. J. Clin. Invest. 90:447-455. |
| 22. |
Edelstein, P. H.
1981.
Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens.
J. Clin. Microbiol.
14:298-303 |
| 23. |
Edelstein, P. H., and S. M. Finegold.
1979.
Use of a semiselective medium to culture Legionella pneumophila from contaminated lung specimens.
J. Clin. Microbiol.
10:141-143 |
| 24. |
Engleberg, N. C.,
C. Carter,
D. R. Weber,
N. P. Cianciotto, and B. I. Eisenstein.
1989.
DNA sequence of mip, a Legionella pneumophila gene associated with macrophage infectivity.
Infect. Immun.
57:1263-1270 |
| 25. |
Engleberg, N. C.,
D. J. Drutz, and B. I. Eisenstein.
1984.
Cloning and expression of Legionella pneumophila antigens in Escherichia coli.
Infect. Immun.
44:222-227 |
| 26. |
Ernst, R. K.,
E. C. Yi,
L. Guo,
K. B. Lim,
J. L. Burns,
M. Hackett, and S. I. Miller.
1999.
Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa.
Science.
286:1561-1565 |
| 27. | Fettes, P. S., M. Susa, J. Hacker, and R. Marre. 2000. Characterisation of the Legionella pneumophila gene ligA. Int. J. Med. Microbiol. 290:239-250[Medline]. |
| 28. | Fields, B. S. 1996. The molecular ecology of legionellae. Trends Microbiol. 4:286-290[CrossRef][Medline]. |
| 29. | Fields, B. S., T. A. Nerad, T. K. Sawyer, C. H. King, J. M. Barbaree, W. T. Martin, W. E. Morrill, and G. N. Sanden. 1990. Characterization of an axenic strain of Hartmannella vermiformis obtained from an investigation of nosocomial legionellosis. J. Protozool. 37:581-583[Medline]. |
| 30. | Francis, M. S., and C. J. Thomas. 1997. Mutants in the CtpA copper transporting P-type ATPase reduce virulence of Listeria monocytogenes. Microb. Pathog. 22:67-78[CrossRef][Medline]. |
| 31. | Ganz, T., and R. I. Lehrer. 1994. Defensins. Curr. Opin. Immunol. 6:584-589[CrossRef][Medline]. |
| 32. | Gao, L. Y., O. S. Harb, and Y. Abu Kwaik. 1997. Utilization of similar mechanisms by Legionella pneumophila to parasitize two evolutionarily distant host cells, mammalian macrophages and protozoa. Infect. Immun. 65:4738-4746[Abstract]. |
| 33. | Garcia-del Portillo, F., J. W. Foster, M. E. Maguire, and B. B. Finlay. 1992. Characterisation of the micro-environment of Salmonella typhimurium-containing vacuoles within MDCK epithelial cells. Mol. Microbiol. 6:3289-3297[Medline]. |
| 34. | Garcia Vescovi, E., F. C. Soncini, and E. A. Groisman. 1996. Mg2+ as an extracellular signal: environmental regulation of Salmonella virulence. Cell 84:165-174[CrossRef][Medline]. |
| 35. |
Garrity, G. M.,
E. M. Elder,
B. Davis,
R. M. Vickers, and A. Brown.
1982.
Serological and genotypic diversity among serogroup 5- reacting environmental Legionella isolates.
J. Clin. Microbiol.
15:646-653 |
| 36. |
Giacometti, A.,
O. Cirioni,
F. Barchiesi,
M. S. Del Prete,
M. Fortuna,
F. Caselli, and G. Scalise.
2000.
In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically.
Antimicrob. Agents. Chemother.
44:1694-1696 |
| 37. |
Guina, T.,
E. C. Yi,
H. Wang,
M. Hackett, and S. I. Miller.
2000.
A PhoP-regulated outer membrane protease of Salmonella enterica serovar Typhimurium promotes resistance to alpha-helical antimicrobial peptides.
J. Bacteriol.
182:4077-4086 |
| 38. | Gunn, J. S., K. B. Lim, J. Krueger, K. Kim, L. Guo, M. Hackett, and S. I. Miller. 1998. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol. Microbiol. 27:1171-1182[CrossRef][Medline]. |
| 39. | Guo, L., K. B. Lim, C. M. Poduje, M. Daniel, J. S. Gunn, M. Hackett, and S. I. Miller. 1998. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell. 95:189-198[CrossRef][Medline]. |
| 40. | Halablab, M. A., M. Bazin, L. Richards, and J. Pacy. 1990. Ultra-structure and localisation of formazan formed by human neutrophils and amoebae phagocytosing virulent and avirulent Legionella pneumophila. FEMS Microbiol. Immunol. 2:295-301[Medline]. |
| 41. |
Hancock, R. E., and M. G. Scott.
2000.
The role of antimicrobial peptides in animal defenses.
Proc. Natl. Acad. Sci. USA
97:8856-8861 |
| 42. |
Harb, O. S., and Y. Abu Kwaik.
2000.
Essential role for the Legionella pneumophila Rep helicase homologue in intracellular infection of mammalian cells.
Infect. Immun.
68:6970-6978 |
| 43. |
Heithoff, D. M.,
C. P. Conner,
U. Hentschel,
F. Govantes,
P. C. Hanna, and M. J. Mahan.
1999.
Coordinate intracellular expression of Salmonella genes induced during infection.
J. Bacteriol.
181:799-807 |
| 44. | Hickey, E. K., and N. P. Cianciotto. 1994. Cloning and sequencing of the Legionella pneumophila fur gene. Gene 143:117-121[CrossRef][Medline]. |
| 45. | Higgins, D. G., and P. M. Sharp. 1988. CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene. 73:237-244[CrossRef][Medline]. |
| 46. |
Horwitz, M. A.
1987.
Characterisation of avirulent mutant Legionella pneumophila that survive but do not multiply within human monocytes.
J. Exp. Med.
166:1310-1328 |
| 47. |
Horwitz, M. A.
1983.
The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes.
J. Exp. Med.
158:2108-2126 |
| 48. | Horwitz, M. A., and S. C. Silverstein. 1980. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J. Clin. Invest. 66:441-450. |
| 49. | Hu, K. H., E. Liu, K. Dean, M. Gingras, W. DeGraff, and N. J. Trun. 1996. Overproduction of three genes leads to camphor resistance and chromosome condensation in Escherichia coli. Genetics 143:1521-1532[Abstract]. |
| 50. |
Joshi, A. D., and M. S. Swanson.
1999.
Comparative analysis of Legionella pneumophila and Legionella micdadei virulence traits.
Infect. Immun.
67:4134-4142 |
| 51. |
Kato, A.,
H. Tanabe, and R. Utsumi.
1999.
Molecular characterization of the PhoP-PhoQ two-component system in Escherichia coli K-12: identification of extracellular Mg2+-responsive promoters.
J. Bacteriol.
181:5516-5520 |
| 52. |
Krogfelt, K. A.,
M. Hjulgaard,
K. Sorensen,
P. S. Cohen, and M. Givskov.
2000.
rpoS gene function is a disadvantage for Escherichia coli BJ4 during competitive colonization of the mouse large intestine.
Infect. Immun.
68:2518-2524 |
| 53. | Leippe, M., J. Andra, R. Nickel, E. Tannich, and H. J. Muller-Eberhard. 1994. Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes. Mol. Microbiol. 14:895-904[Medline]. |
| 54. | Liles, M. R., P. H. Edelstein, and N. P. Cianciotto. 1999. The prepilin peptidase is required for protein secretion by and the virulence of the intracellular pathogen Legionella pneumophila. Mol. Microbiol. 31:959-970[CrossRef][Medline]. |
| 55. |
Lindquist, D. S.,
G. Nygaard,
W. L. Thacker,
R. F. Benson,
D. J. Brenner, and H. W. Wilkinson.
1988.
Thirteenth serogroup of Legionella pneumophila isolated from patients with pneumonia.
J. Clin. Microbiol.
26:586-587 |
| 56. |
Marra, A.,
S. J. Blander,
M. A. Horwitz, and H. A. Shuman.
1992.
Identification of a Legionella pneumophila locus required for intracellular multiplication in human macrophages.
Proc. Natl. Acad. Sci. USA
89:9607-9611 |
| 57. |
Matthews, M., and C. R. Roy.
2000.
Identification and subcellular localization of the Legionella pneumophila IcmX protein: a factor essential for establishment of a replicative organelle in eukaryotic host cells.
Infect. Immun.
68:3971-3982 |
| 58. | McKinney, R. M., R. K. Porschen, P. H. Edelstein, M. L. Bissett, P. P. Harris, S. P. Bondell, A. G. Steigerwalt, R. E. Weaver, M. E. Ein, D. S. Lindquist, R. S. Kops, and D. J. Brenner. 1981. Legionella longbeachae species nova, another etiologic agent of human pneumonia. Ann. Intern. Med. 94:739-743. |
| 59. | McKinney, R. M., L. Thacker, P. P. Harris, K. R. Lewallen, G. A. Hebert, P. H. Edelstein, and B. M. Thomason. 1979. Four serogroups of Legionnaires' disease bacteria defined by direct immunofluorescence. Ann. Intern. Med. 90:621-624. |
| 60. |
McKinney, R. M.,
H. W. Wilkinson,
H. M. Sommers,
B. J. Fikes,
K. R. Sasseville,
M. M. Yungbluth, and J. S. Wolf.
1980.
Legionella pneumophila serogroup six: isolation from cases of legionellosis, identification by immunofluorescence staining, and immunological response to infection.
J. Clin. Microbiol.
12:395-401 |
| 61. | Merrell, D. S., and A. Camilli. 1999. The cadA gene of Vibrio cholerae is induced during infection and plays a role in acid tolerance. Mol. Microbiol. 34:836-849[CrossRef][Medline]. |
| 62. |
Miller, S. I., and J. J. Mekalanos.
1990.
Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages.
J. Bacteriol.
172:2485-2490 |
| 63. | Nash, T. W., D. M. Libby, and M. A. Horwitz. 1984. Interaction between the Legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone. J. Clin. Invest. 74:771-782. |
| 64. | O'Connell, W. A., J. M. Bangsborg, and N. P. Cianciotto. 1995. Characterization of a Legionella micdadei mip mutant. Infect. Immun. 63:2840-2845[Abstract]. |
| 65. | O'Connell, W. A., E. K. Hickey, and N. P. Cianciotto. 1996. A Legionella pneumophila gene that promotes hemin binding. Infect. Immun. 64:842-848[Abstract]. |
| 66. | Pearlman, E., A. H. Jiwa, N. C. Engleberg, and B. I. Eisenstein. 1988. Growth of Legionella pneumophila in a human macrophage-like (U937) cell line. Microb. Pathog. 5:87-95[CrossRef][Medline]. |
| 67. |
Peschel, A.,
M. Otto,
R. W. Jack,
H. Kalbacher,
G. Jung, and F. Gotz.
1999.
Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides.
J. Biol. Chem.
274:8405-8410 |
| 68. |
Reeves, M. W.,
L. Pine,
S. H. Hutner,
J. R. George, and W. K. Harrell.
1981.
Metal requirements of Legionella pneumophila.
J. Clin. Microbiol.
13:688-695 |
| 69. | Rowbotham, T. J. 1986. Current views on the relationships between amoebae, legionellae and man. Isr. J. Med. Sci. 22:678-689[Medline]. |
| 70. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 71. |
Segal, G., and H. A. Shuman.
1999.
Legionella pneumophila utilizes the same genes to multiply within Acanthamoeba castellanii and human macrophages.
Infect. Immun.
67:2117-2124 |
| 72. |
Soncini, F. C.,
E. Garcia Vescovi,
F. Solomon, and E. A. Groisman.
1996.
Molecular basis of the magnesium deprivation response in Salmonella typhimurium: identification of PhoP-regulated genes.
J. Bacteriol.
178:5092-5099 |
| 73. | Steinberg, D. A., M. A. Hurst, C. A. Fujii, A. H. Kung, J. F. Ho, F. C. Cheng, D. J. Loury, and J. C. Fiddes. 1997. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 41:1738-1742[Abstract]. |
| 74. |
St. John, G., and H. M. Steinman.
1996.
Periplasmic copper-zinc superoxide dismutase of Legionella pneumophila: role in stationary-phase survival.
J. Bacteriol.
178:1578-1584 |
| 75. |
Sturgill-Koszycki, S., and M. S. Swanson.
2000.
Legionella pneumophila replication vacuoles mature into acidic, endocytic organelles.
J. Exp. Med.
192:1261-1272 |
| 76. | Sundstrom, C., and K. Nilsson. 1976. Establishment and characterisation of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer. |